ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Update on US Regulatory Review of Roxadustat in Anaemia of Chronic Kidney Disease
August 12, 2021The US FDA has issued a complete response letter (CRL) regarding the New Drug Application (NDA) for roxadustat for the treatment of anemia of chronic kidney disease (CKD), in both non-dialysis dependent (NDD) and dialysis-dependent (DD) adult patients.
Pharma Sources Insight January 2025
